How do you taper off methadone?

Methadone Tapering Strategy

For methadone tapering, reduce the dose by less than 10% of the current dose every 10-14 days, with final doses requiring extremely small reductions (as low as 1 mg or less) before complete cessation, and expect the process to take many months to years for patients on long-term therapy. 1

Taper Rate and Duration

The FDA label explicitly states that dose reductions should be less than 10% of the established tolerance or maintenance dose, with 10-14 day intervals between reductions 1. This is more conservative than general opioid tapering guidelines, which often suggest 10% weekly reductions 2.

Critical distinction: Methadone requires slower tapering than other opioids due to its:

• Long and variable half-life (7-59 hours)
• Tissue accumulation in liver and other organs
• Delayed peak respiratory effects
• Complex pharmacokinetics with incomplete cross-tolerance 1

Research supports even more gradual approaches:

• Tapers lasting 12-52 weeks show 3.6x higher success rates, and those >52 weeks show 6.7x higher success compared to tapers <12 weeks 3
• Reductions of <5 mg/week are superior to larger reductions, with <2.5 mg/week optimal for low-relapse-risk patients 4
• Successful tapers use a stepped schedule with dose decreases in only 25-50% of weeks, interspersed with stabilization periods 3

Hyperbolic (Proportional) Reduction Pattern

Use proportional reductions (1-10% of the most recent dose) rather than fixed linear reductions 5. The hyperbolic relationship between opioid dose and mu-receptor occupancy means that as doses get lower, even small absolute reductions cause disproportionately large receptor changes and withdrawal symptoms. This pharmacodynamic principle explains why final doses must be extremely small (1 mg methadone or less) before complete cessation 5.

Withdrawal Management

Expect and preemptively treat withdrawal symptoms with:

• Clonidine (α2-agonist, directly attenuates withdrawal but monitor for hypotension)
• Lofexidine (FDA-approved for opioid withdrawal, less hypotension risk)
• Tizanidine (alternative α2-agonist, weaker but safer)
• Short-term adjuvants: gabapentin, trazodone, mirtazapine for anxiety/insomnia 2
• Loperamide for GI symptoms (caution: arrhythmia risk at high doses) 2

Protracted withdrawal syndrome may persist for months after cessation—dysphoria, insomnia, anhedonia—and must be anticipated and managed 2.

Patient Factors Predicting Success

Higher success rates with:

• Lower baseline methadone dose 6
• Slower taper rate (3.3 vs 6.4 mg/week in successful vs relapsed patients) 6
• Higher motivation and absence of tobacco use 6
• Voluntary participation with proper informed consent 2

Structured Taper Agreement

Document a formal taper agreement including 7:

• Specific weekly/monthly reduction schedule
• Expected risks (withdrawal, pain fluctuations, anxiety)
• Regular appointments and urine toxicology monitoring
• Concurrent pain management strategies
• Provisions for taper failure (revised schedule, addiction specialist referral, or maintenance therapy)
• Reassurance that pain will be treated and patient will not be abandoned 7

Critical Safety Warnings

Do NOT convert outpatients to methadone from other opioids for tapering purposes due to complex pharmacokinetics, nonlinear morphine equivalency, and documented high lethality 2. This is especially dangerous in high-dose opioid users.

High relapse risk: Only 13% of patients attempting methadone taper achieve sustained success (no relapse, hospitalization, or mortality within 18 months) 3. The FDA label explicitly warns patients of this high relapse risk 1.

Alternative: Consider Buprenorphine Transition

For patients requiring faster discontinuation or experiencing methadone-related adverse effects (e.g., QTc prolongation), transition to buprenorphine may be appropriate, though this requires specialized protocols and typically inpatient management 8. Buprenorphine has growing evidence for maintenance in patients with opioid dependence 7.

Realistic Timeline

For patients on long-term methadone maintenance (80-120 mg/day typical maintenance dose 1), expect tapering to require several months to years 2, 1. A patient on 100 mg tapered at 10% every 2 weeks would require approximately 9-12 months minimum, with the final weeks requiring even slower reductions.